MedPath

Comparison the effect of Progestrone and Nifedipine in prevention of preterm delivery

Phase 2
Conditions
Preterm delivery.
Preterm labour and delivery
Registration Number
IRCT2017031133016N1
Lead Sponsor
Vice chancellor for research, Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
80
Inclusion Criteria

Main exclusion criteria: diabetes; hypertension; seizure; migraine; heart disease; kidney disease; asthma; active liver disease; thrombophlebitis; cervix insufficiency; twins and more pregnancy; cervical dilation = 4 cm; intrauterine growth retardation; PROM; vaginal bleeding; tocolysis contraindications include fetal distress, chorioamnionitis, severe preeclampsia, hemodynamic instability; trauma history; smoking; history of taking cimetidine, beta blockers, digoxin or nitrates

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction of uterine contractions. Timepoint: Every 20 minutes after the treatment start. Method of measurement: Manual by.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath